Preliminary Activity and Safety Results of KRAS G12C Inhibitor Glecirasib (JAB-21822) in Patients with Pancreatic Cancer and Other Solid Tumors.
JOURNAL OF CLINICAL ONCOLOGY（2024）
关键词
283-324,261-492-2769,613-135-244-3829,261-492-5651-9270-10662,283-197-481,261-566-9263,261-492-3532-2370-5109,38092-25821,38092-25821,38116-38094-8
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要